Enliven Therapeutics Inc. (ELVN) — Financial Flexibility Index
Enliven Therapeutics Inc. (ELVN) has a Financial Flexibility Index of -1.22x as of June 2026. Free cash flow of $-18.43 Million (operating CF $-18.53 Million minus capex $99.00K) represents -1% of total liabilities ($15.07 Million). Check Enliven Therapeutics Inc. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Enliven Therapeutics Inc. Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Enliven Therapeutics Inc. across 9 annual periods. For the full cash flow conversion analysis, see ELVN cash flow metrics.
Annual Financial Flexibility Index for Enliven Therapeutics Inc. (2017–2025)
Year-by-year free cash flow to debt coverage for Enliven Therapeutics Inc.. Explore ELVN operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.21x | $-70.14 Million | $-70.30 Million | $16.68 Million | ▲ +8.5% |
| 2024 | -4.60x | $-73.15 Million | $-73.19 Million | $15.91 Million | ▼ -95.2% |
| 2023 | -2.35x | $-61.12 Million | $-61.27 Million | $25.96 Million | ▼ -1098.1% |
| 2022 | -0.20x | $-31.46 Million | $-32.08 Million | $160.12 Million | ▲ +93.3% |
| 2021 | -2.93x | $-18.94 Million | $-19.13 Million | $6.47 Million | ▼ -132.6% |
| 2020 | -1.26x | $-8.07 Million | $-8.53 Million | $6.41 Million | ▲ +74.6% |
| 2019 | -4.96x | $-21.74 Million | $-21.88 Million | $4.38 Million | ▼ -3.5% |
| 2018 | -4.79x | $-8.78 Million | $-8.78 Million | $1.83 Million | ▲ +19.0% |
| 2017 | -5.91x | $-8.79 Million | $-8.79 Million | $1.49 Million | — |